← Back to PeopleResearcherGabriele CorsoCo-founder and CEO at BoltzLinkedIn@GabriCorsoWebsiteGabriele Corso is a PhD student at MIT CSAIL1Mentions1Articles1OutletsCompanies CoveredMcMaster University1MIT CSAIL1Stoked Bio1ArticlesMost recent firstMentioned InReferenced in coverageAI Discovers New Antibiotic For Gut HealthMITpositiveOct 7, 2025“Co-developed DiffDock, a generative AI model that predicted how drug molecules bind to bacterial proteins to discover enterololin antibiotic.”